Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DESLORATADINE vs DEUCRAVACITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DESLORATADINE vs DEUCRAVACITINIB: Safety Overview

Metric DESLORATADINE DEUCRAVACITINIB
Total FAERS Reports 3,141 2,386
Deaths Reported 160 36
Death Rate 5.1% 1.5%
Hospitalizations 1,389 121
Average Patient Age 47.8 yrs 56.8 yrs
% Female Patients 61.7% 63.8%
FDA Approval Date Apr 19, 2012 Sep 9, 2022
Manufacturer Bionpharma Inc. E.R. Squibb & Sons, L.L.C.
Route ORAL ORAL
Marketing Status Prescription Prescription